跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Cognizanz - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Cognizanz
Approved
STANDARD
Cognizanz
Sinil Pharmaceutical Co., Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
62f7fb096e77f1dc
Company
Sinil Pharmaceutical Co., Ltd.
Type
Standard
Approval Details
Approval Id
62f7fb096e77f1dc
Drug Approval Philippines Name
Cognizanz
Product Name
Cognizanz
Registration Number
DRP-8007
Brand Name
Cognizanz
Generic Name
Rivastigmine
Dosage Form
Transdermal Drug Delivery System
Dosage Strength
9.5mg/24 hours (18mg)
Manufacturer
Sinil Pharmaceutical Co., Ltd.
Importer
JLT Pharma, Inc.
Issuance Date
27 July 2023
Expiry Date
26 October 2028
Pharmacologic Category
Antidementia (Reversible Acetylcholinesterase inhibitor)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
62f7fb096e77f1dc
Type
Standard
Back to Philippines FDA Approvals